Market Analysis

Cutting Edge Information reports 42% of pharma firms outsource phase IV research

Published in Drug Week, February 16th, 2007

According to a new report by pharmaceutical business intelligence leader Cutting Edge Information, 42.6% of companies that have the internal infrastructure in place to manage phase IV studies in-house still choose to outsource much of the work associated with their post-marketing studies.

The report "phase IV Clinical Trials: Post-Marketing Study Management Structure, Strategy & Benchmarks" finds that company size influences the outsourcing of phase IV activities.

Of the companies surveyed, only 44% of small companies and 40% of mid-sized companies have the internal infrastructure to support phase IV management. This lack of internal infrastructure...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2007-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry